test

Sean Tan

@Stempoint Capital Lp

Latest period2024 - Q3ReportedManaged Assets$334.017MTotal holdings50
Assets growth rate-1.84%Assets growth rate (2-Q avg)-5.94%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Stempoint Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 50 positions.

Assets under management

The assets under management (AUM) of Stempoint Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 334.017M in assets, with a quarterly growth rate of -1.84% and a 2-quarter average growth rate of -5.94%. The portfolio is managed by Sean Tan, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PCSCPerceptive Cap Solutions Cor
Recent Activity
0.45%
$1.503M
150,000 shares@ $10.02 avg price
TRMLTourmaline Bio Inc
Recent Activity
New Position
0.43%
$1.427M
55,523 shares@ $25.71 avg price
CAPRCapricor Therapeutics Inc
Recent Activity
New Position
0.43%
$1.424M
93,638 shares@ $15.22 avg price
ALKSAlkermes Plc
Recent Activity
New Position
0.41%
$1.369M
48,918 shares@ $28.0 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
New Position
0.41%
$1.338M
83,662 shares@ $15.99 avg price
MBXMbx Biosciences Inc
Recent Activity
New Position
0.39%
$1.299M
50,000 shares@ $25.98 avg price
CYTKCytokinetics Inc
Recent Activity
New Position
0.23%
$763,699
14,464 shares@ $52.8 avg price
RVMDRevolution Medicines Inc
Recent Activity
New Position
0.23%
$755,259
16,654 shares@ $45.36 avg price
ATXSAstria Therapeutics Inc
Recent Activity
New Position
0.19%
$618,876
56,287 shares@ $11.0 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
Decreased -92.65%
0.16%
$531,131
19,900 shares@ $26.69 avg price